Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort-Reference-Cited by-同舟云学术

Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort

Published:2015-10 Issue:10 Volume:45 Page:1054-1065
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Mallett A.¹²,Hughes P.³,Szer J.⁴,Tuckfield A.⁴,Van Eps C.²⁵,Cambell S. B.²⁵,Hawley C.²⁵,Burke J.²⁵,Kausman J.⁶,Hewitt I.⁷,Parnham A.⁸,Ford S.⁹,Isbel N.²⁵

Affiliation:

1. Department of Renal Medicine; Royal Brisbane and Women's Hospital; Brisbane Queensland Australia

2. Centre for Kidney Disease Research; Centre for Chronic Disease; CKD.QLD; School of Medicine; University of Queensland; Brisbane Queensland Australia

3. Department of Nephrology; Royal Melbourne Hospital; Melbourne Victoria Australia

4. Department of Clinical Haematology and BMT Service; Royal Melbourne Hospital; Melbourne Victoria Australia

5. Department of Nephrology; Princess Alexandra Hospital; Brisbane Queensland Australia

6. Department of Nephrology; The Royal Children's Hospital Melbourne; Melbourne Victoria Australia

7. Department of Nephrology; Princess Margaret Hospital for Children; Perth Western Australia Australia

8. Department of Nephrology; Gold Coast Hospital; Gold Coast Queensland Australia

9. Department of Nephrology; Monash Medical Centre; Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.12864/fullpdf

Reference52 articles.

1. Atypical hemolytic uremic syndrome;Loirat;Orphanet J Rare Dis,2011

2. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults;Fremeaux-Bacchi;Clin J Am Soc Nephrol,2013

3. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome;Le Quintrec;Am J Transplant,2013

4. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome;Fan;Mol Immunol,2013

5. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype;Bresin;J Am Soc Nephrol,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Incidence and Graft Survival Rate in Kidney Transplant Recipients With De Novo Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis;Transplant International;2024-01-23

2. New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses;Renal Failure;2023-08-10

3. Modern Approaches to the Management of Children with Atypical Hemolytic Uremic Syndrome;Pediatric pharmacology;2022-04-21

4. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort;PLOS ONE;2021-11-08

5. The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies;Biomedicines;2020-09-16